Clinical efficacy of rhGM-CSF gel and medical collagen sponge on deep second-degree burns of infants: A randomized clinical trial.

Background: This study aimed to observe clinical efficacy of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) gel, medical collagen sponge and rhGM-CSF gel in combination with medical collagen sponge on deep second-degree burns of head, face or neck in infants.

Methods: A total of 108 infants with deep second-degree burns on head, face or neck were randomly divided into rhGM-CSF group, medical collagen sponge group, and rhGM-CSF + medical collagen sponge group. The scab dissolving time, healing time, bacterial positive rate and Vancouver scar scale were evaluated and analyzed.

ZnCoO composite catalyst accelerated removal of phenylic contaminants containing of Cr(VI) in dielectric barrier discharge reactor: Process and mechanism study.

The degradation of phenylic contaminants (phenol, hydroquinone, nitrobenzene, p-nitrophenol) containing Cr(VI) has been investigated in a dielectric barrier discharge (DBD) system using a ZnCoO composite catalyst. The ZnCoO nanowires combined with multi-walled carbon nanotubes (MWNTs) on a sponge substrate in the discharge system can induce a decrease in the corona inception voltage and discharge becomes more stable resulting in an improvement in the energy utilization efficiency. With the synergistic degradation of phenylic species containing Cr(VI), the total elimination efficiency was further improved.